Narayana I. Narasimhan
Narayana I. Narasimhan publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.
- World rank
- #781,325 of 7,710,434 ranked researchers
- Rank in United States
- #261,335 of 1,627,098
- Works
- 89
- Citations
- 4.1k
- Citations per work
- 46.6
What does Narayana I. Narasimhan research?
Narayana I. Narasimhan's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5764.1%
- Medicine5764.1%
- Everything else1719.3%
- Life Sciences1516.6%
- 1Pulmonary and Respiratory Medicine18% of their works
- 2Oncology17% of their works
- 3Molecular Biology17% of their works
- 4Hematology13% of their works
- 5Genetics11% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
Which keywords describe Narayana I. Narasimhan's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Prognostic Factors, Rituximab, ALK Inhibitors, EGFR Mutations, Chemotherapy and BCR-ABL.
- DNA
- KRAS Mutations
- Cetuximab
- Genomic Profiles
- Signaling
- Chronic Lymphocytic Leukemia
- BCR-ABL
- EGFR Mutations
- Rituximab
- Targeted Therapy
- Clinical Trials
- Prognostic Factors
- ALK Inhibitors
- Chemotherapy
- Imatinib
- Genomic Aberrations
- mTOR
- Small-Cell Lung Cancer
- Classification
- Lymphoma
- Topoisomerases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Trials342 topics
- Targeted Therapy342 topics
- Prognostic Factors282 topics
- Rituximab252 topics
- ALK Inhibitors241 topic
- EGFR Mutations241 topic
- Chemotherapy223 topics
- BCR-ABL211 topic
- Imatinib211 topic
- Chronic Lymphocytic Leukemia181 topic
- Genomic Aberrations181 topic
- Signaling121 topic
- mTOR121 topic
- Genomic Profiles101 topic
- Small-Cell Lung Cancer101 topic
- Cetuximab71 topic
- Classification71 topic
- KRAS Mutations71 topic
- Lymphoma71 topic
- DNA51 topic
- Topoisomerases51 topic
Where does Narayana I. Narasimhan work?
Narayana I. Narasimhan's main affiliation in the publication record is Ariadne Diagnostics (United States), United States.
How many publications and citations does Narayana I. Narasimhan have?
OpenAlex counts 89 works and 4,145 citations for Narayana I. Narasimhan, an h-index of 26, ranking #781,325 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Narayana I. Narasimhan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.